FAP acts as a tumor promoter via epithelial-mesenchymal transition (EMT) in 18 human oral squamous cell carcinoma (OSCC). The present study was designed to 19 investigate the interaction proteins with FAP and explore the precise mechanism 20 of FAP promoting EMT in OSCC. IP-MS analysis confirmed that DPP9 was an 21 interacting protein of FAP. DPP9 was down-regulated in OSCC tissue samples 22 compared with MNT using immunohistochemistry and quantitative-PCR detection.
observing no FAP in tFAP group. This suggested that intracellular part of FAP may 94 be the cooperating site with DPP9. (Fig.1d) To confirm FAP will not be regulated 95 by DPP9, when transfecting siRNA to silence DPP9, we detected FAP expression 96 in both SCC9 and SCC25 groups and observe FAP no difference (Fig.3a) . Fig.2a ). Three randomized-picked paired OSCC tumor tissues (TUM) and the 112 MNT were analyzed and western blotting revealed that DPP9 protein were 113 markedly low expression in the tumor tissues compared to the MNT. (Fig.2c) . OSCC patients for up to 40months were used to assess the value of DPP9 for 134 predicting patient survival in OSCC patients. These samples were stained using a 135 DPP9 antibody and scored using a standard method (summarized in Table 1 ).
136
Compared to the adjacent non-tumor OSCC in which DPP9 was strongly 137 detected, DPP9 was undetectable or found to be only expressed at low levels,
138
DPP9 was low expressed in OSCC specimens ( Fig.2c ). We analyzed the 139 association between DPP9 and the clinicopathological features of OSCC. As 140 showed in Table 1 , strong associations were observed between DPP9 expression 141 and clinical stage (p=0.036), T classification (p=0.017), N classification(p=0.041).
142
However, the expression of DPP9 was not associated with age, gender and promoted cell growth in vitro. Colony formation assay showed that suppressing 157 DPP9 significantly stimulated cell proliferation (Fig.3b ). The growth curves 158 determined by CCK-8 assay showed that suppression DPP9 significantly 159 stimulated cell viability in comparison with si-con cells ( Fig.3c ). Taken together, 160 these results suggested that DPP9 significantly inhibited cell growth in vitro. (Fig.6a ). As showed in Figure 6 , results of the CCK8 assay and colony formation 221 assay demonstrated that the DPP9 plasmid decreased the cell proliferation and 222 tumorigenesis (Fig.6b,6e) . Consistently, cells numbers of DPP9 plasmid treated 223 cells of migration and invasion was reduced (Fig.6d) . Also, the adhesion test 224 showed further reduction of adhesion ability of the treated cells (Fig.6c ). And remains to be elucidated.
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In our study, we verified that DPP9 is significantly downregulated in OSCC samples an anti-cancer role for DPP9 in OSCC. To the best of our knowledge, this is the first 285 study to explore the clinical prognostic value of DPP9 in OSCC.
286
EMT has been confirmed to play a significant role in promoting metastasis in 287 epithelium-derived carcinoma. Accumulating evidence has shown that EMT confers 288 adhesion, migration, invasion and metastasis capacity, stemness and multidrug 289 resistance in tumor cells (17) (18) (19) (20) washed twice with cold serum-free medium, and resuspended with serum-free 404 medium. To evaluate cancer growth in vivo, 2 × 10 6 treated cells were 405 independently injected subcutaneously into the left axilla in 5 nude mice each 406 group. Every five days, the length (L) and width (W) of tumors were measured 407 using calipers, and their volumes were calculated using the equation (L ×W 2 )/2.
408
On day 20th, the animals were euthanized, and the tumors were excised, 409 weighed, serial sliced and stained with hematoxylin and eosin (HE). Overall, our study suggests that FAP induces EMT by down-regulating DPP9 gene in 419 OSCC. DPP9 may play a potential tumor depression role in OSCC.DPP9 420 overexpression was able to reverse tumorigenesis and metastasis caused by FAP in 421 OSCC cells. These could be a vigorous therapeutic strategy for future OSCC 422 treatment, but the specific mechanism and functional sites still need to be further 423 explored.
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